跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,548 条关于
“David Sinclair”
全部
1,548
临床试验
55
药物
12
机构
81
资讯
1,400
上个月
David Sinclair Launches Lifespan, a Scientist-Led Media Platform, as First Human Epigenetic Reprogramming Trial Advances
3个月前
Life Biosciences Doses First Patient with Cellular Reprogramming Therapy for Glaucoma, Eyes Broader Anti-Aging Potential
7个月前
Life Biosciences Secures First FDA Approval for Human Epigenetic Reprogramming Trial to Reverse Vision Loss
4个月前
Infinite Epigenetics Acquires Tally Health in Largest Epigenetic Age Testing Deal
10个月前
Life Biosciences Appoints Veteran Biotech Leader David Guyer to Board as Company Prepares for First Human Trials
去年
Life Biosciences Partners with Singapore Institute to Advance Epigenetic Therapies for Age-Related Diseases
9个月前
FDA Reverses Course on NMN, Reinstates Dietary Supplement Status After Legal Challenge
3个月前
Semaglutide, Omega-3s, and Diet Shift Next-Generation Epigenetic Aging Clocks in Human Studies
3个月前
Ray Kurzweil Predicts 'Longevity Escape Velocity' by 2032, Fueled by AI-Driven Drug Discovery
上个月
High-Throughput CRISPR Screening Emerges as Key Tool to Separate Causal Aging Regulators From Correlative Markers
第 1 页,共 140 页
上一页
下一页